AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $622,295 | +4.7% | 36,844 | -12.5% | 0.00% | – |
| Q4 2023 | $594,537 | +90.5% | 42,106 | +38.9% | 0.00% | – |
| Q3 2023 | $312,152 | -17.3% | 30,306 | +32.3% | 0.00% | – |
| Q2 2023 | $377,491 | -56.3% | 22,906 | -75.7% | 0.00% | – |
| Q1 2023 | $864,695 | -28.2% | 94,399 | -43.9% | 0.00% | – |
| Q4 2022 | $1,204,498 | +90.6% | 168,226 | +33.4% | 0.00% | – |
| Q3 2022 | $632,000 | +50.5% | 126,135 | -26.6% | 0.00% | – |
| Q2 2022 | $420,000 | -70.1% | 171,952 | -16.4% | 0.00% | – |
| Q1 2022 | $1,406,000 | -8.2% | 205,794 | +8.6% | 0.00% | – |
| Q4 2021 | $1,531,000 | -5.2% | 189,516 | +15.0% | 0.00% | – |
| Q3 2021 | $1,615,000 | +72.0% | 164,784 | +18.2% | 0.00% | – |
| Q2 2021 | $939,000 | -13.9% | 139,464 | +15.6% | 0.00% | – |
| Q1 2021 | $1,091,000 | +74.8% | 120,693 | +29.3% | 0.00% | – |
| Q4 2020 | $624,000 | +49.6% | 93,316 | +12.7% | 0.00% | – |
| Q3 2020 | $417,000 | +178.0% | 82,798 | +346.5% | 0.00% | – |
| Q2 2020 | $150,000 | -59.6% | 18,542 | -79.2% | 0.00% | – |
| Q3 2019 | $371,000 | +43.8% | 89,192 | 0.0% | 0.00% | – |
| Q2 2019 | $258,000 | +101.6% | 89,192 | 0.0% | 0.00% | – |
| Q1 2019 | $128,000 | -44.3% | 89,192 | 0.0% | 0.00% | – |
| Q4 2018 | $230,000 | -41.3% | 89,192 | 0.0% | 0.00% | – |
| Q3 2018 | $392,000 | -51.8% | 89,192 | -32.8% | 0.00% | – |
| Q2 2018 | $813,000 | -18.0% | 132,662 | -2.5% | 0.00% | – |
| Q1 2018 | $992,000 | +0.4% | 136,110 | +12.9% | 0.00% | – |
| Q4 2017 | $988,000 | +194.0% | 120,537 | +276.2% | 0.00% | – |
| Q3 2017 | $336,000 | -4.3% | 32,043 | +0.8% | 0.00% | – |
| Q2 2017 | $351,000 | +16.2% | 31,782 | +1.7% | 0.00% | – |
| Q1 2017 | $302,000 | -4.4% | 31,259 | +2.8% | 0.00% | – |
| Q4 2016 | $316,000 | – | 30,401 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 600,000 | $8,436,000 | 5.68% |
| Vivo Capital, LLC | 3,972,099 | $55,847,712 | 5.16% |
| Tri Locum Partners LP | 1,189,518 | $16,724,623 | 4.23% |
| Knott David M Jr | 333,000 | $4,682 | 1.87% |
| MPM BioImpact LLC | 783,242 | $11,012,383 | 1.71% |
| SCHULHOFF & CO INC | 137,000 | $1,926,220 | 0.87% |
| 1620 INVESTMENT ADVISORS, INC. | 1,000 | $14,060 | 0.01% |
| Ameritas Investment Partners, Inc. | 9,055 | $127,313 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $16 | 0.00% |
| CWM, LLC | 99 | $1 | 0.00% |